Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232086 · ClinicalTrials.gov registry record · NA
Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults
A NA study, sponsored by Environmental Protection Agency (EPA).
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03232086: Completed NA study, sponsored by Environmental Protection Agency (EPA).
NCT03232086 is a NA study that has completed, run by Environmental Protection Agency (EPA). The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03232086, a NA study, has completed, sponsored by Environmental Protection Agency (EPA).
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Purpose: To determine whether exposure to levels of fine particles that are close to the current standard will cause cardiovascular changes in healthy individuals.
Primary Outcome
10 minute electrocardiogram recording (measured by Holter ECG) in which the
Interventions
- OTHER Clean Air
- OTHER PM2.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2020-07-30 |
| Phase | NA |
What the finished NCT03232086 record still lists
NCT03232086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Clean Air is the first listed.
NCT03232086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03232086 about?
NCT03232086 is a clinical study titled "Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults". Purpose: To determine whether exposure to levels of fine particles that are close to the current standard will cause cardiovascular changes in healthy individuals.
What is the current status of trial NCT03232086?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-01-16. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03232086?
The interventions under investigation include: Clean Air (OTHER), PM2.5 (OTHER).
Who is sponsoring clinical trial NCT03232086?
This trial is sponsored by Environmental Protection Agency (EPA), which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03232086's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI